The application of tumor cell-derived vesicles in oncology therapy
-
Ximei Xu [1] ; Yin Xiang [1] ; Yang Yang [1] ; Kai Liu [1] ; Zhiwei Cui [1] ; Xiaodong Tong [1] ; Junliang Chen [1] ; Fang Hou [1] ; Zhiqiang Luo [1]
-
[1] The People’s Hospital of Leshan, Leshan, 614000, Sichuan, China
-
- Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 25, Nº. 2 (February), 2023, págs. 364-374
- Idioma: inglés
- Texto completo no disponible (Saber más ...)
-
Resumen
Tumor cell-derived vesicles are released by tumor cells, have a phospholipid bilayer, and are widely distributed in various biological fluids. In recent years, it has been found that tumor cell-derived vesicles contain proteins, metabolites and nucleic acids and can be delivered to recipient cells to perform their physiological functions, such as mediating specific intercellular communication, activating or inhibiting signaling pathways, participating in regulating the modulation of tumor microenvironment and influencing tumor development, which can be used for early detection and diagnosis of cancer. In addition, tumor cell-derived vesicles exhibit multiple properties in tumor therapeutic applications and may serve as a new class of delivery systems. In this review, we elaborate on the application of tumor cell-derived vesicles in oncology therapy.
